Routine

Antidepressant discontinuation syndrome

Pharmacological · Psychiatry / Behavioural
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Symptoms after abrupt stopping or dose reduction of an antidepressant (especially short half-life SSRIs/SNRIs like paroxetine or venlafaxine) - flu-like symptoms, dizziness, electric-shock sensations, insomnia, irritability and gastrointestinal upset.

Red flags

  • Features suggesting serotonin syndrome
  • Return of suicidal ideation (relapse)
  • Severe or prolonged symptoms

Assessment

Differential diagnosis

  • Depressive/anxiety relapse
  • Serotonin syndrome (if a new serotonergic agent added)
  • Viral illness
  • Vestibular disorder
  • Hypoglycaemia

Investigations

  • Clinical diagnosis from timing after dose change
  • Medication history including half-life and adherence
  • Exclude other causes if atypical (bloods, glucose)
  • Distinguish from relapse of the underlying disorder

Management

  • Confirm the temporal relationship to stopping or reducing the antidepressant
  • Reassure - symptoms are usually self-limiting over one to two weeks
  • Restart the antidepressant (or reduce more slowly) if symptoms are severe or distressing
  • Plan a gradual taper going forward
  • Differentiate from relapse of depression/anxiety, which needs different management

Drugs & doses

Reinstate the original antidepressant then taper slowly
Consider bridging with a longer half-life agent (e.g. fluoxetine) in specialist practice
Symptomatic relief as needed

Disposition

Usually managed in primary care; reinstate and taper; safety-net for relapse.

Complications & pitfalls

  • Misdiagnosis as relapse leading to unnecessary escalation
  • Distress and functional impairment
  • Non-adherence to future treatment

Exam pearls

  • Electric-shock (brain zap) sensations and dizziness within days of stopping point to discontinuation, not relapse
  • Paroxetine and venlafaxine (short half-lives) are the usual culprits - taper slowly

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.